市場調查報告書

全球抗衰老市場:按產品,療法,人口普查行業分析和到2030年的增長預測

Anti-Aging Market Research Report: By Product, Treatment, Demography - Global Industry Analysis and Growth Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 968418
出版日期 內容資訊 英文 269 Pages
商品交期: 2-3個工作天內
價格
全球抗衰老市場:按產品,療法,人口普查行業分析和到2030年的增長預測 Anti-Aging Market Research Report: By Product, Treatment, Demography - Global Industry Analysis and Growth Forecast to 2030
出版日期: 2020年08月01日內容資訊: 英文 269 Pages
簡介

2019年,全球抗衰老市場為1915億美元。在2020-2030年的預測期內,該市場預計將以8.1%的複合年增長率增長,到2030年將達到4214億美元。

市場的主要增長因素是提高認識的研討會和會議的數量,老年人口的迅速增加,可支配收入的增加,技術進步,醫療和旅遊業的擴大以及整容手術的數量增加。

本報告研究了全球抗衰老市場,包括市場規模和預測,機會,增長和限制因素,COVID-19的影響,產品/療法/人口統計/區域市場分析以及競爭。它提供了諸如主要公司的狀況和概況之類的信息。

目錄

第1章調查背景

  • 調查目的
  • 市場定義
  • 調查範圍
    • 副產品
    • 通過治療
    • 人口統計
    • 按地區
    • 分析期間
    • 市場數據報告單位
      • 交易量
  • 主要利益相關者

第2章調查方法

第3章執行摘要

第4章簡介

  • 市場細分的定義
    • 副產品
      • 抗皺
      • 頭髮顏色
      • 紫外線吸收
      • 抗拉痕
      • 其他
    • 通過治療
      • 頭髮生長
      • 防止色素沉著
      • 成人痤瘡治療
      • 隆胸
      • 吸脂
      • 化學剝皮
      • 其他
    • 人口統計
      • X世代
      • 嬰兒潮
      • Y世代
  • 市場動態
    • 趨勢
      • 易於使用的家用抗衰老設備的消費趨勢在增長
    • 生長因子
      • 通過研討會和會議獲得認可
      • 老年人口迅速增加
      • 可支配收入增加
      • 技術進步
      • 不斷發展的醫療旅遊業
      • 抗衰老整容手術的數量增加
      • 分析增長因素對市場預測的影響
    • 抑製器
      • 抗衰老設備的高成本
      • 嚴格的法規要求
      • 與使用抗衰老設備相關的風險和副作用
      • 分析限制因素對市場預測的影響
    • 市場機會
      • 未滿足對微創或無創治療的需求
      • 越來越多地使用社交網絡和電子商務平台
  • COVID-19的影響
  • 波特的五力分析
  • 目標受眾群體統計
    • 性別:總人口
    • 性別:尋常痤瘡的患病率
    • 按年齡:總人口
    • 按年齡分類:尋常痤瘡的患病率
    • 按年齡分類:皮膚/年輕化和抗衰老產品的目標人群
    • 按年齡劃分:皮膚/年輕化和抗衰老產品的男性目標人群
    • 按年齡劃分:皮膚/年輕化和抗衰老產品的女性目標人群
  • 監管框架分析
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲

第5章全球市場規模和預測

  • 副產品
    • 按類型劃分的抗皺市場
  • 通過治療
  • 人口統計
  • 按地區

第6章北美市場規模和預測

第7章歐洲市場規模和預測

第8章亞太市場規模和預測

第9章拉丁美洲市場規模和預測

第10章中東/非洲的市場規模和預測

第11章競爭情況

  • 提供的公司和產品列表
  • 主要公司的產品基準
  • 大公司的戰略發展
    • 併購
    • 設施擴充
    • 產品發佈和批准
    • 聯盟與合作
    • 其他發展

第12章公司簡介

  • The Procter & Gamble Company
  • Nu Skin Enterprises Inc.
  • Hologic Inc.
  • Candela Corporation
  • Home Skinovations Ltd.
  • Allergan plc
  • The Estee Lauder Companies Inc.
  • L'Oreal SA
  • Orlane S.A.
  • Age Sciences Inc.
  • Alma Lasers Ltd.
  • Lumenis Ltd.
  • Panasonic Corporation
  • TRIA Beauty Inc.
  • Carol Cole Company Inc.
  • YA-MAN LTD.
  • MTG Co. Ltd.
  • Koninklijke Philips N.V.
  • LightStim
  • Spectrum Brands Holdings Inc.
  • Conair Corporation
  • Amorepacific Corporation
  • Project E Beauty
  • Dr. Dennis Gross Skincare LLC
  • Beauty Bioscience Inc.
  • FOREO AB
  • Cyden Limited
  • Jeisys Medical Inc.
  • Imdad LLC

第13章附錄

  • 縮寫
  • 來源和參考
  • 相關報告
目錄

Title:
Anti-Aging Market Research Report: By Product (Anti-Wrinkle, Hair Color, Ultraviolet Absorption, Anti-Stretch Mark), Treatment (Hair Restoration, Anti-Pigmentation, Adult Acne Therapy, Breast Augmentation, Liposuction, Chemical Peel), Demography (Generation X, Baby Boomers, Generation Y) - Global Industry Analysis and Growth Forecast to 2030.

The major driving factors for the anti-aging market are the rising number of awareness-raising seminars and conferences, surging geriatric population, increasing disposable income, technological advancements, expanding medical tourism sector, and escalating cosmetic surgery volume. These factors will lead to an increase in the industry revenue from $191.5 billion in 2019 to $421.4 billion in 2030, at an 8.1% CAGR during 2020-2030 (forecast period). Products used to diminish the signs of aging are easily available at physical stores and online portals.

A key factor aiding the anti-aging market advance is the rising number of seminars and conferences being organized to make plastic surgeons, students, and the general public about the advanced anti-aging treatments. For instance, the Aesthetic & Anti-Aging Medicine World Congress (AMWC) hosted by EuroMediCom (Informa Group) in April 2019 in Monte Carlo, Monaco, included five knowledge sharing and discussion sessions on anti-aging and aesthetics. Formerly, the Aesthetic & Anti-Aging Medicine World Congress 13th Edition was hosted in Thailand in September 2018 by the American Academy of Anti-Aging Medicine (A4M).

Another major reason the demand for anti-aging treatments and products is increasing is the booming geriatric population. The United Nations says that the number of people in the age group of 65 and above will surge from 703 million in 2019 to 1.5 billion by 2050. With age, people experience stem cell and fibrous tissue loss, which leads to dryness, wrinkles, sagging, and pigmentary alteration. Therefore, in order to continue looking young and attractive, the geriatric population regularly uses anti-aging remedies, which tighten and revitalize the skin, in addition to making people look young.

North America is the dominant region in the anti-aging market currently, owing to the rising plastic surgery volume and geriatric population. The UN expects the number of elderly people on the continent to increase to 96.2 million by 2050 from 59.9 million in 2019. This, coupled with the growing volume of plastic surgeries, is expected to result in a massive surge in the demand for various therapies and products that help people look young and aesthetically appealing.

Hence, as more people age and their awareness regarding how they can reverse or physically hide the effects of this process rises, the market will keep blossoming.

Table of Contents

 Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Product
    • 1.3.2 Market Segmentation by Treatment
    • 1.3.3 Market Segmentation by Demography
    • 1.3.4 Market Segmentation by Region
    • 1.3.5 Analysis Period
    • 1.3.6 Market Data Reporting Unit
      • 1.3.6.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Product
      • 4.1.1.1 Anti-wrinkle
        • 4.1.1.1.1 Botox
        • 4.1.1.1.2 Dermal fillers
      • 4.1.1.2 Hair color
      • 4.1.1.3 UV absorption
      • 4.1.1.4 Anti-stretch mark
      • 4.1.1.5 Others
    • 4.1.2 By Treatment
      • 4.1.2.1 Hair restoration
      • 4.1.2.2 Anti-pigmentation
      • 4.1.2.3 Adult acne therapy
      • 4.1.2.4 Breast augmentation
      • 4.1.2.5 Liposuction
      • 4.1.2.6 Chemical peel
      • 4.1.2.7 Others
    • 4.1.3 By Demography
      • 4.1.3.1 Generation X
      • 4.1.3.2 Baby boomers
      • 4.1.3.3 Generation Y
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing inclination of consumers toward easy-to-use, at-home anti-aging devices
    • 4.2.2 Drivers
      • 4.2.2.1 Increasing awareness through seminars and conferences
      • 4.2.2.2 Surge in geriatric population
      • 4.2.2.3 Rising disposable income
      • 4.2.2.4 Advancements in technology
      • 4.2.2.5 Growing medical tourism industry
      • 4.2.2.6 Increasing volume of anti-aging cosmetic procedures
      • 4.2.2.7 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 High cost of anti-aging devices
      • 4.2.3.2 Stringent regulatory requirements
      • 4.2.3.3 Risks and side-effects associated with the use of anti-aging devices
      • 4.2.3.4 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Unmet need for minimally or non-invasive treatments
      • 4.2.4.2 Rising use of social networking and e-commerce platforms
  • 4.3 Impact of COVID-19
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Intensity of Rivalry
    • 4.4.4 Threat of New Entrants
    • 4.4.5 Threat of Substitutes
  • 4.5 Target Audience - Demographics
    • 4.5.1 Total Population, By Gender
    • 4.5.2 Prevalence of Acne Vulgaris, By Gender
    • 4.5.3 Total Population, By Age
    • 4.5.4 Prevalence of Acne Vulgaris, By Age
    • 4.5.5 Target Population for Skin/Rejuvenation and Anti-Aging Products, By Age
    • 4.5.6 Male Target Population for Skin/Rejuvenation and Anti-Aging Products, By Age
    • 4.5.7 Female Target Population for Skin/Rejuvenation and Anti-Aging Products, By Age
  • 4.6 Regulatory Framework Analysis
    • 4.6.1 North America
    • 4.6.2 Europe
    • 4.6.3 APAC
    • 4.6.4 LATAM
    • 4.6.5 MEA

Chapter 5. Global Market Size and Forecast

  • 5.1 By Product
    • 5.1.1 Anti-Wrinkle Market, by Type
  • 5.2 By Treatment
  • 5.3 By Demography
  • 5.4 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Product
    • 6.1.1 Anti-Wrinkle Market, by Type
  • 6.2 By Treatment
  • 6.3 By Demography
  • 6.4 By Country
    • 6.4.1 U.S. Anti-Aging Market
      • 6.4.1.1 By product
        • 6.4.1.1.1 Anti-wrinkle market, by type
      • 6.4.1.2 By treatment
      • 6.4.1.3 By demography
    • 6.4.2 Canada Anti-Aging Market
      • 6.4.2.1 By product
        • 6.4.2.1.1 Anti-wrinkle market, by type
      • 6.4.2.2 By treatment
      • 6.4.2.3 By demography

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Product
    • 7.1.1 Anti-Wrinkle Market, by Type
  • 7.2 By Treatment
  • 7.3 By Demography
  • 7.4 By Country
    • 7.4.1 Germany Anti-Aging Market
      • 7.4.1.1 By product
        • 7.4.1.1.1 Anti-wrinkle market, by type
      • 7.4.1.2 By treatment
      • 7.4.1.3 By demography
    • 7.4.2 U.K. Anti-Aging Market
      • 7.4.2.1 By product
        • 7.4.2.1.1 Anti-wrinkle market, by type
      • 7.4.2.2 By treatment
      • 7.4.2.3 By demography
    • 7.4.3 France Anti-Aging Market
      • 7.4.3.1 By product
        • 7.4.3.1.1 Anti-wrinkle market, by type
      • 7.4.3.2 By treatment
      • 7.4.3.3 By demography
    • 7.4.4 Italy Anti-Aging Market
      • 7.4.4.1 By product
        • 7.4.4.1.1 Anti-wrinkle market, by type
      • 7.4.4.2 By treatment
      • 7.4.4.3 By demography
    • 7.4.5 Spain Anti-Aging Market
      • 7.4.5.1 By product
        • 7.4.5.1.1 Anti-wrinkle market, by type
      • 7.4.5.2 By treatment
      • 7.4.5.3 By demography

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Product
    • 8.1.1 Anti-Wrinkle Market, by Type
  • 8.2 By Treatment
  • 8.3 By Demography
  • 8.4 By Country
    • 8.4.1 Japan Anti-Aging Market
      • 8.4.1.1 By product
        • 8.4.1.1.1 Anti-wrinkle market, by type
      • 8.4.1.2 By treatment
      • 8.4.1.3 By demography
    • 8.4.2 China Anti-Aging Market
      • 8.4.2.1 By product
        • 8.4.2.1.1 Anti-wrinkle market, by type
      • 8.4.2.2 By treatment
      • 8.4.2.3 By demography
    • 8.4.3 India Anti-Aging Market
      • 8.4.3.1 By product
        • 8.4.3.1.1 Anti-wrinkle market, by type
      • 8.4.3.2 By treatment
      • 8.4.3.3 By demography
    • 8.4.4 South Korea Anti-Aging Market
      • 8.4.4.1 By product
        • 8.4.4.1.1 Anti-wrinkle market, by type
      • 8.4.4.2 By treatment
      • 8.4.4.3 By demography

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Product
    • 9.1.1 Anti-Wrinkle Market, by Type
  • 9.2 By Treatment
  • 9.3 By Demography
  • 9.4 By Country
    • 9.4.1 Brazil Anti-Aging Market
      • 9.4.1.1 By product
        • 9.4.1.1.1 Anti-wrinkle market, by type
      • 9.4.1.2 By treatment
      • 9.4.1.3 By demography
    • 9.4.2 Mexico Anti-Aging Market
      • 9.4.2.1 By product
        • 9.4.2.1.1 Anti-wrinkle market, by type
      • 9.4.2.2 By treatment
      • 9.4.2.3 By demography

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Product
    • 10.1.1 Anti-Wrinkle Market, by Type
  • 10.2 By Treatment
  • 10.3 By Demography
  • 10.4 By Country
    • 10.4.1 Saudi Arabia Anti-Aging Market
      • 10.4.1.1 By product
        • 10.4.1.1.1 Anti-wrinkle market, by type
      • 10.4.1.2 By treatment
      • 10.4.1.3 By demography

Chapter 11. Competitive Landscape

  • 11.1 List of Players and Their Offerings
  • 11.2 Product Benchmarking of Key Players
  • 11.3 Strategic Developments of Key Players
    • 11.3.1 Mergers and Acquisitions
    • 11.3.2 Facility Expansions
    • 11.3.3 Product Launches and Approvals
    • 11.3.4 Partnerships and Collaborations
    • 11.3.5 Other Developments

Chapter 12. Company Profiles

  • 12.1 The Procter & Gamble Company
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Nu Skin Enterprises Inc.
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
    • 12.2.3 Key Financial Summary
  • 12.3 Hologic Inc.
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Key Financial Summary
  • 12.4 Candela Corporation
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
  • 12.5 Home Skinovations Ltd.
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
  • 12.6 Allergan plc
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
    • 12.6.3 Key Financial Summary
  • 12.7 The Estee Lauder Companies Inc.
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
    • 12.7.3 Key Financial Summary
  • 12.8 L'Oreal SA
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
    • 12.8.3 Key Financial Summary
  • 12.9 Orlane S.A.
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
  • 12.10 Age Sciences Inc.
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
  • 12.11 Alma Lasers Ltd.
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
  • 12.12 Lumenis Ltd.
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
  • 12.13 Panasonic Corporation
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
  • 12.14 TRIA Beauty Inc.
    • 12.14.1 Business Overview
    • 12.14.2 Product and Service Offerings
  • 12.15 Carol Cole Company Inc.
    • 12.15.1 Business Overview
    • 12.15.2 Product and Service Offerings
  • 12.16 YA-MAN LTD.
    • 12.16.1 Business Overview
    • 12.16.2 Product and Service Offerings
  • 12.17 MTG Co. Ltd.
    • 12.17.1 Business Overview
    • 12.17.2 Product and Service Offerings
  • 12.18 Koninklijke Philips N.V.
    • 12.18.1 Business Overview
    • 12.18.2 Product and Service Offerings
    • 12.18.3 Key Financial Summary
  • 12.19 LightStim
    • 12.19.1 Business Overview
    • 12.19.2 Product and Service Offerings
  • 12.20 Spectrum Brands Holdings Inc.
    • 12.20.1 Business Overview
    • 12.20.2 Product and Service Offerings
    • 12.20.3 Key Financial Summary
  • 12.21 Conair Corporation
    • 12.21.1 Business Overview
    • 12.21.2 Product and Service Offerings
  • 12.22 Amorepacific Corporation
    • 12.22.1 Business Overview
    • 12.22.2 Product and Service Offerings
    • 12.22.3 Key Financial Summary
  • 12.23 Project E Beauty
    • 12.23.1 Business Overview
    • 12.23.2 Product and Service Offerings
  • 12.24 Dr. Dennis Gross Skincare LLC
    • 12.24.1 Business Overview
    • 12.24.2 Product and Service Offerings
  • 12.25 Beauty Bioscience Inc.
    • 12.25.1 Business Overview
    • 12.25.2 Product and Service Offerings
  • 12.26 FOREO AB
    • 12.26.1 Business Overview
    • 12.26.2 Product and Service Offerings
  • 12.27 Cyden Limited
    • 12.27.1 Business Overview
    • 12.27.2 Product and Service Offerings
  • 12.28 Jeisys Medical Inc.
    • 12.28.1 Business Overview
    • 12.28.2 Product and Service Offerings
  • 12.29 Imdad LLC
    • 12.29.1 Business Overview
    • 12.29.2 Product and Service Offerings

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 GDP PER CAPITA BASED ON PURCHASING POWER PARITY (PPP), USD (2015-2018)
  • TABLE 3 COSMETIC PROCEDURES PERFORMED WORLDWIDE IN 2018
  • TABLE 4 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 5 COST OF ANTI-AGING DEVICES
  • TABLE 6 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 7 MINIMALLY AND NON-INVASIVE ANTI-AGING TREATMENTS
  • TABLE 8 TOTAL POPULATION, BY GENDER (2019)
  • TABLE 9 PREVALENCE OF ACNE VULGARIS, BY GENDER (2019)
  • TABLE 10 TOTAL POPULATION, BY AGE, IN THOUSANDS (2019)
  • TABLE 11 PREVALENCE OF ACNE VULGARIS, BY AGE (2019)
  • TABLE 12 TARGET POPULATION FOR SKIN REJUVENATION/ANTI-AGING PRODUCTS, BY AGE, IN THOUSANDS (2019)
  • TABLE 13 MALE TARGET POPULATION FOR SKIN REJUVENATION/ANTI-AGING PRODUCTS, BY AGE, IN THOUSANDS (2019)
  • TABLE 14 FEMALE TARGET POPULATION FOR SKIN REJUVENATION/ANTI-AGING PRODUCTS, BY AGE, IN THOUSANDS (2019)
  • TABLE 15 CFDA CLASSWISE REGULATIONS FOR MEDICAL DEVICES
  • TABLE 16 REGULATORY AND APPROVAL BODIES FOR MEDICAL DEVICES IN SOME LATAM COUNTRIES
  • TABLE 17 GLOBAL ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 18 GLOBAL ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 19 GLOBAL ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 20 GLOBAL ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 21 GLOBAL ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 22 GLOBAL ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 23 GLOBAL ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 24 GLOBAL ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 25 GLOBAL ANTI-AGING MARKET, BY REGION, $M (2014-2019)
  • TABLE 26 GLOBAL ANTI-AGING MARKET, BY REGION, $M (2020-2030)
  • TABLE 27 NORTH AMERICA ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 28 NORTH AMERICA ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 29 NORTH AMERICA ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 30 NORTH AMERICA ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 31 NORTH AMERICA ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 32 NORTH AMERICA ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 33 NORTH AMERICA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 34 NORTH AMERICA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 35 NORTH AMERICA ANTI-AGING MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 36 NORTH AMERICA ANTI-AGING MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 37 U.S. ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 38 U.S. ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 39 U.S. ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 40 U.S. ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 41 U.S. ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 42 U.S. ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 43 U.S. ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 44 U.S. ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 45 CANADA ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 46 CANADA ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 47 CANADA ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 48 CANADA ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 49 CANADA ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 50 CANADA ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 51 CANADA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 52 CANADA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 53 EUROPE ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 54 EUROPE ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 55 EUROPE ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 56 EUROPE ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 57 EUROPE ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 58 EUROPE ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 59 EUROPE ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 60 EUROPE ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 61 EUROPE ANTI-AGING MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 62 EUROPE ANTI-AGING MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 63 NUMBER OF COSMETIC PROCEDURES PERFORMED IN GERMANY (2018)
  • TABLE 64 GERMANY ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 65 GERMANY ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 66 GERMANY ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 67 GERMANY ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 68 GERMANY ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 69 GERMANY ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 70 GERMANY ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 71 GERMANY ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 72 U.K. ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 73 U.K. ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 74 U.K. ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 75 U.K. ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 76 U.K. ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 77 U.K. ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 78 U.K. ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 79 U.K. ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 80 FRANCE ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 81 FRANCE ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 82 FRANCE ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 83 FRANCE ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 84 FRANCE ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 85 FRANCE ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 86 FRANCE ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 87 FRANCE ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 88 NUMBER OF SURGICAL AND NON-SURGICAL COSMETIC PROCEDURES PERFORMED IN ITALY (2018)
  • TABLE 89 ITALY ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 90 ITALY ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 91 ITALY ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 92 ITALY ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 93 ITALY ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 94 ITALY ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 95 ITALY ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 96 ITALY ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 97 SPAIN ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 98 SPAIN ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 99 SPAIN ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 100 SPAIN ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 101 SPAIN ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 102 SPAIN ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 103 SPAIN ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 104 SPAIN ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 105 APAC ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 106 APAC ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 107 APAC ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 108 APAC ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 109 APAC ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 110 APAC ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 111 APAC ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 112 APAC ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 113 APAC ANTI-AGING MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 114 APAC ANTI-AGING MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 115 JAPAN ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 116 JAPAN ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 117 JAPAN ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 118 JAPAN ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 119 JAPAN ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 120 JAPAN ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 121 JAPAN ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 122 JAPAN ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 123 CHINA ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 124 CHINA ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 125 CHINA ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 126 CHINA ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 127 CHINA ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 128 CHINA ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 129 CHINA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 130 CHINA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 131 INDIA ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 132 INDIA ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 133 INDIA ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 134 INDIA ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 135 INDIA ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 136 INDIA ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 137 INDIA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 138 INDIA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 139 SOUTH KOREA ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 140 SOUTH KOREA ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 141 SOUTH KOREA ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 142 SOUTH KOREA ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 143 SOUTH KOREA ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 144 SOUTH KOREA ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 145 SOUTH KOREA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 146 SOUTH KOREA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 147 LATAM ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 148 LATAM ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 149 LATAM ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 150 LATAM ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 151 LATAM ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 152 LATAM ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 153 LATAM ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 154 LATAM ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 155 LATAM ANTI-AGING MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 156 LATAM ANTI-AGING MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 157 BRAZIL ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 158 BRAZIL ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 159 BRAZIL ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 160 BRAZIL ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 161 BRAZIL ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 162 BRAZIL ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 163 BRAZIL ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 164 BRAZIL ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 165 MEXICO ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 166 MEXICO ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 167 MEXICO ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 168 MEXICO ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 169 MEXICO ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 170 MEXICO ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 171 MEXICO ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 172 MEXICO ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 173 MEA ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 174 MEA ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 175 MEA ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 176 MEA ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 177 MEA ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 178 MEA ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 179 MEA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 180 MEA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 181 MEA ANTI-AGING MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 182 MEA ANTI-AGING MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 183 SAUDI ARABIA ANTI-AGING MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 184 SAUDI ARABIA ANTI-AGING MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 185 SAUDI ARABIA ANTI-WRINKLE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 186 SAUDI ARABIA ANTI-WRINKLE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 187 SAUDI ARABIA ANTI-AGING MARKET, BY TREATMENT, $M (2014-2019)
  • TABLE 188 SAUDI ARABIA ANTI-AGING MARKET, BY TREATMENT, $M (2020-2030)
  • TABLE 189 SAUDI ARABIA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2019)
  • TABLE 190 SAUDI ARABIA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2020-2030)
  • TABLE 191 LIST OF REGIONAL PLAYERS
  • TABLE 192 THE PROCTER & GAMBLE COMPANY - AT A GLANCE
  • TABLE 193 THE PROCTER & GAMBLE COMPANY - KEY FINANCIAL SUMMARY
  • TABLE 194 NU SKIN ENTERPRISES INC. - AT A GLANCE
  • TABLE 195 NU SKIN ENTERPRISES INC. - KEY FINANCIAL SUMMARY
  • TABLE 196 HOLOGIC INC. - AT A GLANCE
  • TABLE 197 HOLOGIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 198 CANDELA CORPORATION - AT A GLANCE
  • TABLE 199 HOME SKINOVATIONS LTD. - AT A GLANCE
  • TABLE 200 ALLERGAN PLC - AT A GLANCE
  • TABLE 201 ALLERGAN PLC - KEY FINANCIAL SUMMARY
  • TABLE 202 THE ESTEE LAUDER COMPANIES INC. - AT A GLANCE
  • TABLE 203 THE ESTEE LAUDER COMPANIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 204 L'OREAL SA - AT A GLANCE
  • TABLE 205 L'OREAL SA - KEY FINANCIAL SUMMARY
  • TABLE 206 ORLANE S.A. - AT A GLANCE
  • TABLE 207 AGE SCIENCES INC. - AT A GLANCE
  • TABLE 208 ALMA LASERS LTD. - AT A GLANCE
  • TABLE 209 LUMENIS LTD. - AT A GLANCE
  • TABLE 210 PANASONIC CORPORATION - AT A GLANCE
  • TABLE 211 PANASONIC CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 212 TRIA BEAUTY INC. - AT A GLANCE
  • TABLE 213 CAROL COLE COMPANY INC. - AT A GLANCE
  • TABLE 214 YA-MAN LTD. - AT A GLANCE
  • TABLE 215 MTG CO. LTD. - AT A GLANCE
  • TABLE 216 KONINKLIJKE PHILIPS N.V. - AT A GLANCE
  • TABLE 217 KONINKLIJKE PHILIPS N.V. - KEY FINANCIAL SUMMARY
  • TABLE 218 LIGHTSTIM - AT A GLANCE
  • TABLE 219 SPECTRUM BRANDS HOLDINGS INC. - AT A GLANCE
  • TABLE 220 SPECTRUM BRANDS HOLDINGS INC. - KEY FINANCIAL SUMMARY
  • TABLE 221 CONAIR CORPORATION - AT A GLANCE
  • TABLE 222 AMOREPACIFIC CORPORATION - AT A GLANCE
  • TABLE 223 AMOREPACIFIC CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 224 PROJECT E BEAUTY - AT A GLANCE
  • TABLE 225 DR. DENNIS GROSS SKINCARE LLC - AT A GLANCE
  • TABLE 226 BEAUTY BIOSCIENCE INC. - AT A GLANCE
  • TABLE 227 FOREO AB - AT A GLANCE
  • TABLE 228 CYDEN LIMITED - AT A GLANCE
  • TABLE 229 JEISYS MEDICAL INC. - AT A GLANCE
  • TABLE 230 IMDAD LLC - AT A GLANCE

LIST OF FIGURES

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL ANTI-AGING MARKET SUMMARY
  • FIG 9 AGING POPULATION AS PERCENTAGE OF TOTAL POPULATION IN MAJOR REGIONS (2019 AND 2050)
  • FIG 10 AVERAGE PERCENTAGE OF MEDICAL TOURISTS WHO AVAILED ANTI-AGING PROCEDURES IN DIFFERENT COUNTRIES (2018)
  • FIG 11 PORTER'S FIVE FORCES ANALYSIS
  • FIG 12 SNAPSHOT OF GLOBAL ANTI-AGING MARKET (2019)
  • FIG 13 GLOBAL ANTI-AGING MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 14 GLOBAL ANTI-AGING MARKET, BY TREATMENT, $M (2014-2030)
  • FIG 15 GLOBAL ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2030)
  • FIG 16 WORLDWIDE MAJOR MARKETS FOR ANTI-AGING PRODUCTS
  • FIG 17 NORTH AMERICA ANTI-AGING MARKET SNAPSHOT
  • FIG 18 PLASTIC SURGERIES AND COSMETIC SURGERIES PERFORMED IN THE U.S. (2019)
  • FIG 19 NORTH AMERICA ANTI-AGING MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 20 NORTH AMERICA ANTI-AGING MARKET, BY TREATMENT, $M (2014-2030)
  • FIG 21 NORTH AMERICA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2030)
  • FIG 22 NORTH AMERICA ANTI-AGING MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 23 EUROPE ANTI-AGING MARKET SNAPSHOT
  • FIG 24 EUROPE ANTI-AGING MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 25 EUROPE ANTI-AGING MARKET, BY TREATMENT, $M (2014-2030)
  • FIG 26 EUROPE ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2030)
  • FIG 27 EUROPE ANTI-AGING MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 28 APAC ANTI-AGING MARKET SNAPSHOT
  • FIG 29 APAC ANTI-AGING MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 30 APAC ANTI-AGING MARKET, BY TREATMENT, $M (2014-2030)
  • FIG 31 APAC ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2030)
  • FIG 32 APAC ANTI-AGING MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 33 LATAM ANTI-AGING MARKET SNAPSHOT
  • FIG 34 LATAM ANTI-AGING MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 35 LATAM ANTI-AGING MARKET, BY TREATMENT, $M (2014-2030)
  • FIG 36 LATAM ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2030)
  • FIG 37 LATAM ANTI-AGING MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 38 MEA ANTI-AGING MARKET SNAPSHOT
  • FIG 39 MEA ANTI-AGING MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 40 MEA ANTI-AGING MARKET, BY TREATMENT, $M (2014-2030)
  • FIG 41 MEA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2014-2030)
  • FIG 42 MEA ANTI-AGING MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 43 PRODUCT BENCHMARKING OF KEY PLAYERS
  • FIG 44 THE PROCTER & GAMBLE COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 45 NU SKIN ENTERPRISES INC. - REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2019)
  • FIG 46 HOLOGIC INC. - REVENUE SPLIT BY PRODUCT SEGMENT AND GEOGRAPHY (2019)
  • FIG 47 ALLERGAN PLC - REVENUE SPLIT BY PRODUCT SEGMENT (2019)
  • FIG 48 THE ESTEE LAUDER COMPANIES INC. - REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2019)
  • FIG 49 L'OREAL SA - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
  • FIG 50 PANASONIC CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 51 KONINKLIJKE PHILIPS N.V. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 52 SPECTRUM BRANDS HOLDINGS INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 53 AMOREPACIFIC CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)